Empagliflozin effects on cyclophosphamide-induced neurotoxicity in rats without diabetes
Turkish Journal of Medical Sciences · 18.02.2025 · 55 (1) · 65-71
DOI: 10.55730/1300-0144.5943 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 18.02.2025. Verfasst von Şerife Ezgi Doğan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Department of Internal Medicine Ankara Training and Research Hospital, Ankara, Turkiye. Hauptthemen laut MEDLINE: Glucosides, Benzhydryl Compounds, Cyclophosphamide, Neurotoxicity Syndromes. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background/aim: The objective of this study is to evaluate the effect of empagliflozin on cyclophosphamide-induced neurotoxicity in rats.Materials and methods: A total of 32 male Wistar rats were separated into 4 groups as 8 rats each: control group, cyclophosphamide group, empagliflozin group and the cyclophosphamide plus empagliflozin group. At the end of the experiment rats' brains were removed for biochemical analysis of oxidative stress parameters (malondialdehyde, total sulfhydryl, total oxidant status and total antioxidant capacity) and histopathological analysis.
Results
Total sulfhydryl levels were increased in group empagliflozin and group empagliflozin and cyclophosphamide compared to the cyclophosphamide group but did not improve histopathological findings. Furthermore, when empagliflozin treatment was used coupled with cyclophosphamide, necrosis was significantly higher.
Conclusion
In conclusion, empagliflozin has no protective effect on cyclophosphamide neurotoxicity in addition it may have neurotoxic effects. Clarification of possible neurotoxic/neuroprotective effects of empagliflozin would be beneficial for diabetic cancer patients who are receiving cyclophosphamide chemotherapy and empagliflozin together.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology, Department of Internal Medicine Ankara Training and Research Hospital, Ankara, Turkiye.
- Department of Pathology, Ankara Training and Research Hospital, Ankara, Turkiye.
- Department of Biochemistry, Ankara Training and Research Hospital, Ankara, Turkiye.
ORCID-Profile: Şerife Ezgi Doğan, Şerife Mehlika Kuşkonmaz, Pınar Celepli, Mehmet Şenes, Sema Hücümenoğlu, Cavit Çulha
Zitieren
APA
Doğan, Ş. E., Kuşkonmaz, Ş. M., Celepli, P., Şenes, M., Hücümenoğlu, S., & Çulha, C. (2025). Empagliflozin effects on cyclophosphamide-induced neurotoxicity in rats without diabetes. Turkish Journal of Medical Sciences, 55(1), 65-71. https://doi.org/10.55730/1300-0144.5943
Vancouver
Doğan ŞE, Kuşkonmaz ŞM, Celepli P, Şenes M, Hücümenoğlu S, Çulha C. Empagliflozin effects on cyclophosphamide-induced neurotoxicity in rats without diabetes. Turkish Journal of Medical Sciences. 2025;55(1):65-71. doi:10.55730/1300-0144.5943
BibTeX
@article{Doan2025,
author = {Doğan, Şerife Ezgi and Kuşkonmaz, Şerife Mehlika and Celepli, Pınar and Şenes, Mehmet and Hücümenoğlu, Sema and Çulha, Cavit},
title = {Empagliflozin effects on cyclophosphamide-induced neurotoxicity in rats without diabetes},
journal = {Turkish Journal of Medical Sciences},
year = {2025},
volume = {55},
number = {1},
pages = {65--71},
doi = {10.55730/1300-0144.5943}
}
EUVIMED